aluates Reports

$ 0.0

Automative

Global Zoladex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-11C9278

Global Zoladex Market Size Status and Forecast 2022

BUY CHAPTERS

Global Zoladex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-11C9278

Report

August 2025

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

TerSera

Astrazeneca plc

Zoladex Sales Market Size

The global Zoladex market size was US$ 1048 million in 2024 and is forecast to a readjusted size of US$ 1226 million by 2031 with a CAGR of 2.3% during the forecast period 2025-2031.

Zoladex Sales Market

Zoladex is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin releasing hormone agonist (GnRH agonist). Zoladex (goserelin acetate) Implant is a man-made form of a hormone used in men to treat symptoms of prostate cancer, and in women to treat breast cancer or endometriosis. Zoladex is also used in women to prepare the lining of the uterus for endometrial ablation (a surgery to correct abnormal uterine bleeding).

The Zoladex market is primarily driven by the increasing prevalence of hormone-sensitive cancers such as prostate and breast cancer, particularly in aging populations. As a gonadotropin-releasing hormone (GnRH) agonist, Zoladex plays a critical role in hormone therapy by effectively suppressing sex hormone production. Its long-acting subcutaneous implant formulation reduces the frequency of administration, improving patient compliance compared to daily oral medications. Moreover, the growing awareness of early cancer screening and the expansion of treatment protocols involving hormone therapy in oncology further stimulate market demand. Additionally, Zoladex is widely used in the management of gynecological disorders such as endometriosis and uterine fibroids, where hormonal suppression is essential. Increasing access to healthcare in developing countries and the inclusion of Zoladex in standard treatment guidelines have also contributed to its sustained global adoption.

Despite its therapeutic significance, the Zoladex market faces notable challenges. One of the main issues is the availability of alternative GnRH agonists and antagonists, such as leuprolide and degarelix, which offer similar or improved efficacy with varying administration methods. The cost of treatment can also be a barrier, especially in low-income regions where health insurance coverage is limited. Furthermore, concerns regarding side effects—such as bone density loss, hot flashes, and cardiovascular risks—may lead physicians to consider other options or limit long-term use. Patent expirations and the entry of generic goserelin products in several countries have intensified price competition, impacting the revenue potential for brand-name Zoladex. Regulatory hurdles, especially for biosimilars and generics, further complicate market dynamics.

The global Zoladex market includes several companies. However, AstraZeneca is in a dominant position in the production market, accounting for over 85% of the market share. Asia-Pacific is the largest consumption region, with a consumption market share of nearly 60%. Following Asia-Pacific, Europe is the second largest consumption area with a consumption market share of about 15%. The classification of Zoladex includes 1M Zoladex and 3M Zoladex.

The global Zoladex market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Zoladex Sales Market Report

Report Metric	Details
Report Name	Zoladex Sales Market
Forecasted market size in 2031	US$ 1226 million
CAGR	2.3%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	1M Zoladex 3M Zoladex
By Application: (Core Demand Driver vs Emerging Opportunity)	Prostate Cancer Breast Cancer Endometriosis Fibroids Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	AstraZeneca, TerSera
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Zoladex market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 3M Zoladex in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Breast Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Zoladex value chain, addressing:

FAQ for this report

What is the Zoladex Sales Market size in 2031?

Ans: The Zoladex Sales Market size in 2031 will be US$ 1226 million.

What is the AstraZeneca share in Zoladex Sales Market?

Ans: However, AstraZeneca is in a dominant position in the production market, accounting for over 85% of the market share.

What is the Zoladex Sales Market share by region?

Ans: Following Asia-Pacific, Europe is the second largest consumption area with a consumption market share of about 15%.

Who are the main players in the Zoladex Sales Market report?

Ans: The main players in the Zoladex Sales Market are AstraZeneca, TerSera

What are the Application segmentation covered in the Zoladex Sales Market report?

Ans: The Applications covered in the Zoladex Sales Market report are Prostate Cancer, Breast Cancer, Endometriosis, Fibroids, Others

What are the Type segmentation covered in the Zoladex Sales Market report?

Ans: The Types covered in the Zoladex Sales Market report are 1M Zoladex, 3M Zoladex

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 1M Zoladex

1.2.3 3M Zoladex

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Prostate Cancer

1.3.3 Breast Cancer

1.3.4 Endometriosis

1.3.5 Fibroids

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Zoladex Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Zoladex Revenue Market Share by Region (2020-2025)

2.4 Global Zoladex Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Zoladex Market Size and Prospective (2020-2031)

2.5.2 Europe Zoladex Market Size and Prospective (2020-2031)

2.5.3 China Zoladex Market Size and Prospective (2020-2031)

2.5.4 Japan Zoladex Market Size and Prospective (2020-2031)

2.5.5 South America Zoladex Market Size and Prospective (2020-2031)

2.5.6 Middle East and Africa Zoladex Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Zoladex Historic Market Size by Type (2020-2025)

3.2 Global Zoladex Forecasted Market Size by Type (2026-2031)

3.3 Different Types Zoladex Representative Players

4 Breakdown Data by Application

4.1 Global Zoladex Historic Market Size by Application (2020-2025)

4.2 Global Zoladex Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Zoladex Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Zoladex Players by Revenue (2020-2025)

5.1.2 Global Zoladex Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Zoladex Revenue

5.4 Global Zoladex Market Concentration Analysis

5.4.1 Global Zoladex Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Zoladex Revenue in 2024

5.5 Global Key Players of Zoladex Head office and Area Served

5.6 Global Key Players of Zoladex, Product and Application

5.7 Global Key Players of Zoladex, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Zoladex Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Zoladex Market Size by Type (2020-2025)

6.1.2.2 North America Zoladex Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Zoladex Market Size by Application (2020-2025)

6.1.3.2 North America Zoladex Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Zoladex Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Zoladex Market Size by Type (2020-2025)

6.2.2.2 Europe Zoladex Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Zoladex Market Size by Application (2020-2025)

6.2.3.2 Europe Zoladex Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Zoladex Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Zoladex Market Size by Type (2020-2025)

6.3.2.2 China Zoladex Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Zoladex Market Size by Application (2020-2025)

6.3.3.2 China Zoladex Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Zoladex Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Zoladex Market Size by Type (2020-2025)

6.4.2.2 Japan Zoladex Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Zoladex Market Size by Application (2020-2025)

6.4.3.2 Japan Zoladex Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 South America Market: Players, Segments and Downstream

6.5.1 South America Zoladex Revenue by Company (2020-2025)

6.5.2 South America Market Size by Type

6.5.2.1 South America Zoladex Market Size by Type (2020-2025)

6.5.2.2 South America Zoladex Market Share by Type (2020-2025)

6.5.3 South America Market Size by Application

6.5.3.1 South America Zoladex Market Size by Application (2020-2025)

6.5.3.2 South America Zoladex Market Share by Application (2020-2025)

6.5.4 South America Market Trend and Opportunities

6.6 Middle East and Africa Market: Players, Segments and Downstream

6.6.1 Middle East and Africa Zoladex Revenue by Company (2020-2025)

6.6.2 Middle East and Africa Market Size by Type

6.6.2.1 Middle East and Africa Zoladex Market Size by Type (2020-2025)

6.6.2.2 Middle East and Africa Zoladex Market Share by Type (2020-2025)

6.6.3 Middle East and Africa Market Size by Application

6.6.3.1 Middle East and Africa Zoladex Market Size by Application (2020-2025)

6.6.3.2 Middle East and Africa Zoladex Market Share by Application (2020-2025)

6.6.4 Middle East and Africa Market Trend and Opportunities

7 Key Players Profiles

7.1 AstraZeneca

7.1.1 AstraZeneca Company Details

7.1.2 AstraZeneca Business Overview

7.1.3 AstraZeneca Zoladex Introduction

7.1.4 AstraZeneca Revenue in Zoladex Business (2020-2025)

7.1.5 AstraZeneca Recent Development

7.2 TerSera

7.2.1 TerSera Company Details

7.2.2 TerSera Business Overview

7.2.3 TerSera Zoladex Introduction

7.2.4 TerSera Revenue in Zoladex Business (2020-2025)

7.2.5 TerSera Recent Development

8 Zoladex Market Dynamics

8.1 Zoladex Industry Trends

8.2 Zoladex Market Drivers

8.3 Zoladex Market Challenges

8.4 Zoladex Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

TerSera

Astrazeneca plc

List of Tables

Table 1. Global Zoladex Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Zoladex Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Zoladex Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Zoladex Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Zoladex Revenue Share by Region (2020-2025)

Table 6. Global Zoladex Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Zoladex Revenue Share Forecast by Region (2026-2031)

Table 8. Global Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Zoladex Revenue Market Share by Type (2020-2025)

Table 10. Global Zoladex Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Zoladex Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Zoladex Revenue Market Share by Application (2020-2025)

Table 15. Global Zoladex Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Zoladex Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Zoladex Application

Table 18. Global Zoladex Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Zoladex Market Share by Players (2020-2025)

Table 20. Global Top Zoladex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zoladex as of 2024)

Table 21. Ranking of Global Top Zoladex Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Zoladex Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Zoladex, Headquarters and Area Served

Table 24. Global Key Players of Zoladex, Product and Application

Table 25. Global Key Players of Zoladex, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Zoladex Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Zoladex Revenue Market Share by Company (2020-2025)

Table 29. North America Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Zoladex Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Zoladex Revenue Market Share by Company (2020-2025)

Table 33. Europe Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Zoladex Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Zoladex Revenue Market Share by Company (2020-2025)

Table 37. China Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Zoladex Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Zoladex Revenue Market Share by Company (2020-2025)

Table 41. Japan Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 43. South America Zoladex Revenue by Company (2020-2025) & (US$ Million)

Table 44. South America Zoladex Revenue Market Share by Company (2020-2025)

Table 45. South America Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 46. South America Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 47. Middle East and Africa Zoladex Revenue by Company (2020-2025) & (US$ Million)

Table 48. Middle East and Africa Zoladex Revenue Market Share by Company (2020-2025)

Table 49. Middle East and Africa Zoladex Market Size by Type (2020-2025) & (US$ Million)

Table 50. Middle East and Africa Zoladex Market Size by Application (2020-2025) & (US$ Million)

Table 51. AstraZeneca Company Details

Table 52. AstraZeneca Business Overview

Table 53. AstraZeneca Zoladex Product

Table 54. AstraZeneca Revenue in Zoladex Business (2020-2025) & (US$ Million)

Table 55. AstraZeneca Recent Development

Table 56. TerSera Company Details

Table 57. TerSera Business Overview

Table 58. TerSera Zoladex Product

Table 59. TerSera Revenue in Zoladex Business (2020-2025) & (US$ Million)

Table 60. TerSera Recent Development

Table 61. Zoladex Market Trends

Table 62. Zoladex Market Drivers

Table 63. Zoladex Market Challenges

Table 64. Zoladex Market Restraints

Table 65. Research Programs/Design for This Report

Table 66. Key Data Information from Secondary Sources

Table 67. Key Data Information from Primary Sources

List of Figures

Figure 1. Zoladex Product Picture

Figure 2. Global Zoladex Market Share by Type: 2024 VS 2031

Figure 3. 1M Zoladex Features

Figure 4. 3M Zoladex Features

Figure 5. Global Zoladex Market Share by Application: 2024 VS 2031

Figure 6. Prostate Cancer

Figure 7. Breast Cancer

Figure 8. Endometriosis

Figure 9. Fibroids

Figure 10. Others

Figure 11. Zoladex Report Years Considered

Figure 12. Global Zoladex Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Zoladex Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Zoladex Revenue Market Share by Region: 2020 VS 2024

Figure 15. North America Zoladex Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Europe Zoladex Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. China Zoladex Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Japan Zoladex Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. South America Zoladex Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Middle East and Africa Zoladex Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Global Zoladex Market Share by Players in 2024

Figure 22. Global Top Zoladex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zoladex as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Zoladex Revenue in 2024

Figure 24. North America Zoladex Market Share by Type (2020-2025)

Figure 25. North America Zoladex Market Share by Application (2020-2025)

Figure 26. Europe Zoladex Market Share by Type (2020-2025)

Figure 27. Europe Zoladex Market Share by Application (2020-2025)

Figure 28. China Zoladex Market Share by Type (2020-2025)

Figure 29. China Zoladex Market Share by Application (2020-2025)

Figure 30. Japan Zoladex Market Share by Type (2020-2025)

Figure 31. Japan Zoladex Market Share by Application (2020-2025)

Figure 32. South America Zoladex Market Share by Type (2020-2025)

Figure 33. South America Zoladex Market Share by Application (2020-2025)

Figure 34. Middle East and Africa Zoladex Market Share by Type (2020-2025)

Figure 35. Middle East and Africa Zoladex Market Share by Application (2020-2025)

Figure 36. AstraZeneca Revenue Growth Rate in Zoladex Business (2020-2025)

Figure 37. TerSera Revenue Growth Rate in Zoladex Business (2020-2025)

Figure 38. Bottom-up and Top-down Approaches for This Report

Figure 39. Data Triangulation

Figure 40. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Goserelin Acetate Sustained Release Implant Market Research Report 2024

Global Leuprorelin Acetate Market Insights Forecast to 2030

Global Leuprorelin Acetate Microspheres for Injection Market Research Report 2024

Global Leuprorelin Drugs Market Research Report 2024

Global Gonadorelin Market Insights Forecast to 2030

Global Gonadorelin Acetate Market Insights Forecast to 2030

Global Triptorelin Acetate Market Insights Forecast to 2030

Global Degarelix Market Insights Forecast to 2030

Global Nafarelin Market Insights Forecast to 2030

Global Nafarelin Acetate Market Research Report 2024

Global Leuprolide Market Research Report 2024

Global Alarelin Acetate Market Insights Forecast to 2030

Global Enanton Leucorin Acetate Market Research Report 2024

Global GnRHa Peptide Drugs Market Research Report 2024

Global Aromatase Inhibitors Market Research Report 2024

Ganirelix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Elagolix Drugs Market Research Report 2024

Global Estradiol Norethindrone Acetate Tablets Market Research Report 2024

Global Hormonal Implants Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions